<DOC>
	<DOC>NCT01737216</DOC>
	<brief_summary>Pilot study of Zoledronic acid in combination with first-line chemotherapy in aged patients with lung cancer. The purpose is to assess the effects of Zoledronic acid in combination with first-line chemotherapy in aged patients with lung cancer on bone mineral density gain in the lumbar spine and total hip.</brief_summary>
	<brief_title>Pilot Study of Zoledronic Acid in Combination With First-line Chemotherapy in Aged Patients With Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Signed informed consent form Age â‰¥70 years Performance Status Eastern Cooperative Oncology Group (ECOG) 01 Histologically or cytologically confirmed lung cancer Did not receive bisphosphonate treatment Appear relapse and metastasis receive other bisphosphonate treatment Active or uncontrolled infection Pregnant or lactating women</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Aged</keyword>
	<keyword>patients</keyword>
</DOC>